Ceramic Dental Implants for Tooth Replacement
(SDS Trial)
Trial Summary
What is the purpose of this trial?
This study is a prospective case series clinical study to examine the effectiveness of Ceramic dental implants manufactured by Swiss Dental Solutions (SDS). Participants with an indication from the dentist for teeth extraction and replacement are invited to participate in this study. Participating in this study will involve the use of dental implants manufactured by Swiss Dental Solutions (SDS zirconia dental implants), submission of the case data, including pre-operative information, intra-operative details, and post-operative follow-up data, to the study site and its collaborating partners. The SDS zirconia dental implants used in this research are FDA cleared devices that are available for dental treatments.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are taking bisphosphonates or medications that cause jaw problems, you may not be eligible to participate.
What data supports the effectiveness of the treatment Zirconia Implants for tooth replacement?
Research shows that zirconia implants have good survival and success rates, with minimal bone loss around the implant area, making them a reliable option for tooth replacement. Studies also indicate that zirconia implants can be as effective as titanium implants, especially when surface modifications are applied to improve bone integration.12345
Is it safe to use ceramic (zirconia) dental implants in humans?
How do zirconia implants differ from other dental implant treatments?
Zirconia implants are unique because they are made from a tooth-colored ceramic material, offering a metal-free alternative to traditional titanium implants. They are known for their superior biocompatibility and aesthetic appeal, especially for patients who prefer not to have metal in their bodies. Additionally, zirconia implants have a micro-rough surface that supports bone integration, similar to titanium implants, but with potentially fewer peri-implant infections.79101112
Research Team
Etyene Schnurr, DMD PhD DSc MSc
Principal Investigator
Vizstara Professional Education, Clinical and R & D
Eligibility Criteria
This trial is for patients needing tooth extraction and replacement with dental implants. Participants must be available for at least one year of follow-up, require single or multiple teeth replacement up to three teeth, and have complete medical records including post-operative radiographs.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo tooth extraction and immediate loading of ceramic implants using a minimally invasive approach
Follow-up
Participants are monitored for implant survival, Pink Esthetic Score, and Marginal Bone Loss over a 12-month period
Treatment Details
Interventions
- Zirconia Implants
Find a Clinic Near You
Who Is Running the Clinical Trial?
Swiss Dental Solutions
Lead Sponsor
VISTA Institute for Therapeutic Innovations
Collaborator